Jim Hawryliw

Senior Clinical Consultant - ABIOMED Inc.

[FDIC International @FDICevent]

🚑 EMS Classroom Sessions at FDIC 2026! 🚑

⭐Cardiogenic Shock: The Prehospital Provider's Role in Saving Lives and Shock Team Activations
👨‍⚕️Instructor: William Hallinan, Captain - Spencerport Fire District
📅 Thursday, April 23 at 1:30 PM

Join us for this classroom session exploring the latest practice changing evidence in cardiogenic shock and heart failure, conditions that remain leading causes of death for both the public and firefighters. Learn how new clinical trials, golden hour insights, and evolving shock triage classifications are reshaping prehospital care from first response to advanced practice units. Through case studies and solution driven strategies including ultrasound, prehospital labs, and advanced communications, attendees will gain tools to elevate patient care and more effectively engage cardiogenic shock centers.
*Eligible for CEH/CAPCE Credit

Learn more here: https://t.co/9AXU0WIqt7

Register for #FDIC2026 today: https://t.co/kizWE2YfGP

[Johnson & Johnson MedTech | Heart Recovery @jjmt_heartrecov]

#ACC24 Late-Breaker RCT confirms Impella CP® improves survival by 12.7%, compared to the control arm without Impella, in heart attack with shock. Congratulations to Jacob Møller, MD, and all the independent investigators on today's publication in @NEJM.
https://t.co/l9Xr2oFbTU

[Jim Hawryliw @JimHawryliw]

Heart recovery at its finest! Very Happy to be part of this amazing company!

[Johnson & Johnson MedTech | Heart Recovery @jjmt_heartrecov]

Today Abiomed celebrates 300,000 Impella patients treated!

This is another important milestone our our journey to make heart recovery the global standard of care, and highlights the impact of our mission.

[Jim Hawryliw @JimHawryliw]

Congratulations to Dr. Quentin Orlando and the Upmc Hamot team in Erie, PA for completing their 400th Impella insertion!

#abiomed #impella #heartdisease #heartrecovery #protectedpci

[Jim Hawryliw @JimHawryliw]

@BruckelJeffrey @evandrofilhobr @Babar_Basir @agtruesdell @MusaSharkawiMD @Robert_Maholic

[Seth Bilazarian, MD @DrSethdb]

FIRST CASES OF THE ABIOMED PIVOTAL IMPELLA ECP STUDY....

@Ascensionorg St. John in Detroit, with @DrAmirKaki
Fantastic ECP device performance: easy AoV crossing, LV position optimized, high pump flows & excellent hemodynamic support during 2 unprotected left main Protected PCI

[Johnson & Johnson MedTech | Heart Recovery @jjmt_heartrecov]

Today, Abiomed announced that Impella RP Flex with SmartAssist has received FDA PMA approval. Impella RP Flex is implanted via the internal jugular vein, which enables patient mobility, & has dual-sensor technology designed to optimize patient management. https://t.co/t7Du70wbRN

[Johnson & Johnson MedTech | Heart Recovery @jjmt_heartrecov]

When Jessica Grib was 32 weeks pregnant she developed post-partum cardiomyopathy and went into cardiogenic shock following a C-section. Thankfully, with the help of Impella CP, her heart was able to recover. Hear about her experience from the @TODAYshow: https://t.co/culT6agxTU

[Jim Hawryliw @JimHawryliw]

#abiomed #heartrecovery

[Johnson & Johnson MedTech | Heart Recovery @jjmt_heartrecov]

.@WCVB's "Made In Mass" recently visited Abiomed's Danvers HQ to learn about the innovative technology platforms we make to help recover hearts and save lives. Watch it here:

[Johnson & Johnson MedTech | Heart Recovery @jjmt_heartrecov]

.@WCVB's "Made In Mass" recently visited Abiomed's Danvers HQ to learn about the innovative technology platforms we make to help recover hearts and save lives. Watch it here:

[Jim Hawryliw @JimHawryliw]

#stpatricksday I’m sure my neighbors love me 😀😀😀!! 🍀🍀🍀🍀🍀🍀🍀 @ Harborcreek https://t.co/HgMtAmQiM9

[Johnson & Johnson MedTech | Heart Recovery @jjmt_heartrecov]

Today, Abiomed and CEO Mike Minogue were invited by @Nasdaq to ring the opening bell in honor of #HeartMonth.

Abiomed is THE #HeartRecovery company, and we were delighted to have this opportunity to reaffirm our mission of recovering hearts and saving lives!
#PatientsFirst

[Jim Hawryliw @JimHawryliw]

#NewProfilePic

[Amir Kaki, MD @DrAmirKaki]

I had the privilege and honor to present the EFS work for the 9F ECP at TCT 2021. This powerful technology will change the landscape for complex PCI and High Risk Patients. 4 Liters via 9F equals game changer. Exciting times for our field and our patients!

[Jim Hawryliw @JimHawryliw]

Nice job @RajTayalMD

[Raj Tayal @RajTayalMD]

Sweet 82 yo female with a NASTY left main!! EF 25%, PAD, mesenteric ischemia, recent COVID PNA, turned down for CABG. CI 1.3, opted for 5.0 support. Home POD #4 after heart team approach @ValleyHospital @HMRahimMD @DrAmirKaki @DrTomWaggoner @ziadalinyc @MitulPPatel1 @DrSethdb

[Thomas Waggoner @DrTomWaggoner]

Challenging Case:

72yo WM w/delayed lat STEMI shock. Impella CP DES to Lcx/LAD. TEE: ruptured post pap muscle 4+MR. Impella-assisted TEER w/ XTW x1 on medial A2/P2. Pt d/‘c POD 6. #Clip-Pella case. @TAVRBot @GilbertTangMD @RajTayalMD @JasonFoerst @J_M_McCabe @DrAmirKaki

[Raj Tayal @RajTayalMD]

Witnessed out of hospital cardiac arrest. EF 10% by #POCUS, hypoxic on FiO2 100. V-A ECMO with antegrade distal perfusion and #ImpellaCP placed at bedside WITHOUT Fluoro using only #echofirst guidance for placement. Our team is strong and ready for the #waronshock @ValleyHospital

[Jim Hawryliw @JimHawryliw]

Happy wedding 6th anniversary !! I’m a hard one to handle to say the least :-) @ Riverside Brewing Company https://t.co/ZOCn9Agsev

[Amir Kaki, MD @DrAmirKaki]

Will provide the clinical course and update on this case below, the most challenging SCAI Class E we have ever taken care of. Join us on 5/27 3:30 PM EST for the first Cardiogenic Shock Working Group Global Summit. @NavinKapur4 @JHMontfort10 @ajaysmd @SrihariNaiduMD @agtruesdell